Introduction
Mesial temporal lobe epilepsy (MTLE) is the most common form of epilepsy and is also responsible for a majority of refractory epilepsy. 1 Genetic factors, together with environmental conditions, contribute to the etiology of sporadic MTLE. The calcium homeostasis modulator 1 (CALHM1) gene encodes a glycosylated membrane protein expressed in the brain, and was first reported as a genetic modifier of the age of onset of Alzheimer's disease (AD). 2 Several lines of evidence indicate that CALHM1 is a plausible candidate gene for epilepsy. First, CALHM1 has been proved to be a pore-forming ion channel mediated by both voltage and changes of extracellular Ca 2+ concentration, and experiments from CALHM1 knockout mice suggests the role of CALHM1 in cortical neuronal excitability. 3 Second, since MTLE and AD have shared cognitive and behavioral impairments, similar underlying mechanisms could account for both diseases, thus it is conceivable that CALHM1 would be also associated with some condition of epilepsy. 4 Additionally, a recent study in a Chinese population revealed a positive association between rs11191692 and temporal lobe epilepsy (TLE).
5
Prompted by those findings and the urgency of replication in a population based study, we performed a replication study of Lv et al. by investigating rs11191692 and rs2986017 of CALHM1 in MTLE in a Han Chinese population by a case-control study design.
Materials and methods
A total of 512 patients with MTLE (388 males and 124 females, mean age 31.9 years) and 412 control subjects (244 males and 168 females, mean age 34.2 years) were included in the study by Xuzhou Hospital from November 2004 to October 2012 (Supplementary Table 1 ). All subjects were unrelated individuals of Han Chinese descent, and age and sex ratio were matched between Purpose: Mesial temporal lobe epilepsy (MTLE) is one of the most common forms of epilepsies in adults. The calcium homeostasis modulator 1 gene (CALHM1) has been considered one of the candidate genes that play a role in epileptogenesis due to its function in calcium homeostasis and amyloid b (Ab) regulation. Recently, the association of a single nucleotide polymorphism (rs11191692) of CALHM1 has been reported to be associated with MTLE in Han Chinese, but independent replication is needed. In the present study, rs11191692 and rs2986017 of CALHM1 were determined in 512 MTLE patients and 412 control subjects to investigate the possible involvement of CALHM1 in the etiology of MTLE. Method: Genotyping was determined by polymerase chain reaction-restriction fragment length polymorphism method. Major statistical analyses were performed by SAS. Results: No significant differences in the genotypic or allelic frequencies of both single-nucleotide polymorphisms were revealed between subjects with and without MTLE (rs11191692: P = 0.890 and 0.230; rs2986017: P = 0.581 and 0.072). Further stratification analysis by gender and age, and analysis of clinical features in relation to MTLE also yielded negative results. Conclusion: rs11191692 and rs2986017 of CALHM1 do not contribute substantially to MTLE in Han Chinese.
ß Informed consent for the anonymous use of their DNA for the purposes of this study was obtained from all enrolled subjects. The study was performed with the approval of the ethics committee in the Affiliated Hospital of Xuzhou Medical College.
The genomic DNA was extracted from the peripheral blood by a salting-out protocol. rs11191692 and rs2986017 were genotyped by restriction fragment length polymorphisms (RFLPs) followed by polymerase chain reaction (PCR). The 231-and 248-bp regions harboring rs11191692 and rs2986017 of CALHM1, respectively, were amplified by a standard PCR protocol with primers of rs11191692 (forward 5 0 -AAGGATGGAATCATGCCAAG-3 0 ; reverse 5 0 -CATAGTAGGCACCCAGCACA-3 0 ) and rs2986017(forward 5 0 -AACATGTAGCGCAACACAGC-3 0 and reverse 5 0 -TCCTTCATGAATGG-CATCTG-3 0 ). Detailed PCR conditions are available upon request.
An aliquot (8-10 ml) of the PCR products was digested for 3 h by 10 units/sample of AciI (for genotyping rs11191692) or BseYI (for genotyping rs2986017) at 37 8C. 
Results
The baseline characteristics of our study cohort are shown in Supplementary Table 1. There was no significant difference of age and male/female ratio between MTLE patients and control subjects. Even we have excluded patients who had a definite causal relationship of head trauma, birth injures, and inflammation with epilepsy, a small fraction (3.9%) of our patients reported an antecedent event such as brain trauma or encephalitis but no evidence suggested those were causal events.
Genotypic distributions of rs11191692 and rs2986017 in control subjects were in Hardy-Weinberg equilibrium. No statistical significance was observed for both allelic and genotypic analysis of both SNPs (rs11191692: P = 0.230 and P = 0.890, respectively; rs2986017: P = 0.072 and P = 0.198, respectively, Table 1 ). Consistent with the single SNP tests, no differences were found between the three haplotypes consisting of rs11191692 and rs2986017 (Supplementary Table 2 ). Given the low occurrence of the AA genotype of rs2986017 in our samples, MTLE patients carrying at least one copy of A allele were grouped, and compared to the GG carriers with respect to age at onset, aura % and HS % in Table 1 Genotypic and allelic frequencies of rs2986017 and rs11191692 of CALHM1 in MTLE patients and control subjects. Table 2 , no apparent difference was found for rs11191692 and rs2986017.
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Discussion
Our negative result of rs2986017 is in agreement with Dr. Lv et al.'s study. Accumulative evidences support that rs2986017 is a functional SNP. First, rs2986017 produces an amino-acid substitution at codon 86 (Pro/Leu). Second, in vitro studies have shown that it causes attenuated CALHM1 function resulting in a reduced calcium permeability and low cytoplasmic calcium levels. 2 Third, it is significantly associated with cerebrospinal fluid Ab levels in human samples. 9 Lastly, human genetic studies have repeatedly demonstrated the association between rs2986017 and AD. 2, 10 Since no experimental evidence so far supports the biological validity of rs11191692, the negative results of rs2986017 may indicate the non-relevance of the CALHM1 locus in MTLE in Han Chinese. rs1119162 locates in the 3 0 untranslated region of CALHM1 but does not directly affect the known miRNAs binding sites (see Supplementary Table 3 and Supplementary Figure) .The original odds ratio (OR) of the rs11191692 A allele was 1.42, 5 and always the true effect could be even smaller. 11 Our sample size is able to provide almost 70% power to replicate this allelic association (OR of 1.42) given 30% of the allelic frequency in controls and a Type I error probability of 0.05. If the OR is 1.2, the power of our study will be dropped to 25%, so it is possible that the initial positive finding revealed a true association, but one that is less strong in our samples. If this is the case, then the underpowered sample size should account for the replication failure. Undetected population stratification could also have resulted in non-replication. It is worth noting that our samples are from south China while the original reports were predominantly from the north. The frequency of the rs11191692 A allele in our control population was 29.25%, which is very close to the 29.9% frequency in the Chinese Han data from the Hapmap Project (http://hapmap.ncbi.nlm.nih.gov/), and is higher than that in the original report (around 26%). Indeed, a one-dimensional ''north-south'' population structure has been revealed in over 6000 Han Chinese samples from various provinces of China. 12 So we cannot exclude the possibility that the difference in the CALHM1 haplotypic structure between Northern Chinese and Southern Chinese resulted in nonreplication.
In summary, the present study provides evidence that rs2986017 and rs11191692 in CALHM1 are not associated with MTLE in the Chinese population.
